Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001437749-23-021202
Filing Date
2023-07-31
Accepted
2023-07-31 17:20:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM 425 dffn20230731d_425.htm 425 28989
  Complete submission text file 0001437749-23-021202.txt   31208
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filed by) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Subject) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37942 | Film No.: 231128484
SIC: 2834 Pharmaceutical Preparations